PEOPLE - Syneron Medical makes appointments:
This article was originally published in Clinica
Medical aesthetic device manufacturer Syneron Medical (Yokneam, Israel) has appointed Dan Suesskind and Michael Anghel to its board of directors, serving as both independent directors, and as external directors (for Israeli law purposes). Mr Suesskind is CFO of Teva Pharmaceutical Industries, a generic drug company. Dr Anghel is president and CEO of the Israel Capital Markets and Investments Corporation.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.